Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neutropenia 1Myelodysplastic Syndromes 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Leukemia 1Infections 1Hot Flashes 1Fever 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1

Interventions

pegfilgrastim 22Filgrastim 11Cyclophosphamide 7Docetaxel 6eflapegrastim 4pegylated granulocyte colony-stimulating factor 3Vancomycin 2Itraconazole 2Granulocyte Colony-Stimulating Factor 2Fluorouracil 2Doxorubicin 2posaconazole 1ceftobiprole medocaril 1angiotensin I (1-7) 1Teicoplanin 1Sodium Chloride 1Oxaliplatin 1N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid 1Methotrexate 1Maxy G34 1Mannose-Binding Lectin 1MYL-1401H 1Leucovorin 1Fluconazole 1EC regimen 1Diet, High-Fat 1Cefepime 1Bevacizumab 1Amphotericin B 11-palmitoyl-2-linoleoyl-3-acetyl-rac glycerol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Neutropenia × Mannose-Binding Lectin × Clear all
NCT00886496 2012-06-20

Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia

Enzon Pharmaceuticals, Inc.

Phase 1 Withdrawn
LymphoidMyeloidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Fever, Infections, Leukemia, Lymphoma, Myelodysplastic Syndromes, Neutropenia, Recurrence, Lymphoma, Large B-Cell, Diffuse, Hot Flashes, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡